OMP ST:73850 ! Escherichia coli K-12 JW4099
Contents
Strain Summary
| Strain Name |
Escherichia coli K-12 JW4099 |
|---|---|
| Synonyms |
JW4099-1 |
| Taxon Information |
|
| Genotype |
DE(araD-araB)567 DE(rhaD-rhaB)568 F- Lambda- hsdR514 lacZ4787(del)(::rrnB-3) rph-1 aspA765(del)::FRT-kan-FRT |
| Strain Reference | |
| Strain availability | |
| Ancestry | |
| Annotated phenotypes |
|
Notes
Phenotype Annotation
| Annotation ID | Qualifier | OMP ID | OMP term name | Relative phenotype information | Experimental condition | ECO ID | ECO term name | Reference | Annotation Extension | Notes |
|---|---|---|---|---|---|---|---|---|---|---|
|
OMP_AN:35091 |
OMP:0007953 |
increased population growth at high temperature |
Relative to: OMP_AN:27621 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences:
|
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
| |||
|
OMP_AN:35092 |
OMP:0007878 |
increased resistance to an antimicrobial agent |
Relative to: OMP_AN:27557 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CID:2830968) A22 |
| ||
|
OMP_AN:35093 |
OMP:0007074 |
increased growth factor requirement |
Relative to: OMP_AN:27601 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:32954) Sodium Acetate anhydrous |
| ||
|
OMP_AN:35094 |
OMP:0007071 |
increased organic carbon source utilization |
Relative to: OMP_AN:27611 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:32954) Sodium Acetate anhydrous |
| ||
|
OMP_AN:35095 |
OMP:0006044 |
decreased resistance to beta-lactam |
Relative to: OMP_AN:27530 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:2676) Amoxicillin |
| ||
|
OMP_AN:35096 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27552 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:10110) Azidothymidine |
| ||
|
OMP_AN:35097 |
OMP:0006044 |
decreased resistance to beta-lactam |
Relative to: OMP_AN:27534 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:3501) Cefoxitin sodium hydrate |
| ||
|
OMP_AN:35098 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27548 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:171741) Cerulenin |
| ||
|
OMP_AN:35099 |
OMP:0007903 |
decreased resistance to bile acids |
Relative to: OMP_AN:27585 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CID:23679061) Cholate sodium hydrate |
| ||
|
OMP_AN:35100 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27509 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:27899) Cisplatin-cis-Diamineplatinum(II) dichloride |
| ||
|
OMP_AN:35101 |
OMP:0007902 |
increased resistance to bile acids |
Relative to: OMP_AN:27586 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:9177) Deoxycholate sodium |
| ||
|
OMP_AN:35102 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27501 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:247956) Dibucaine |
| ||
|
OMP_AN:35103 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27572 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:4806) Epigallocatechin gallate (EGCG) |
| ||
|
OMP_AN:35104 |
OMP:0007250 |
increased resistance to a chemical |
Relative to: OMP_AN:27572 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:4806) Epigallocatechin gallate (EGCG) |
| ||
|
OMP_AN:35105 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27550 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:4883) Ethidium Bromide |
| ||
|
OMP_AN:35106 |
OMP:0007074 |
increased growth factor requirement |
Relative to: OMP_AN:27603 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:42758) D-Glucose anhydrous |
| ||
|
OMP_AN:35107 |
OMP:0007071 |
increased organic carbon source utilization |
Relative to: OMP_AN:27613 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:42758) D-Glucose anhydrous |
| ||
|
OMP_AN:35108 |
OMP:0007074 |
increased growth factor requirement |
Relative to: OMP_AN:27604 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:17754) Glycerol |
| ||
|
OMP_AN:35109 |
OMP:0007071 |
increased organic carbon source utilization |
Relative to: OMP_AN:27614 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:17754) Glycerol |
| ||
|
OMP_AN:35110 |
OMP:0006040 |
decreased resistance to quinolone |
Relative to: OMP_AN:27540 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:63598) Levofloxacin |
| ||
|
OMP_AN:35111 |
OMP:0007074 |
increased growth factor requirement |
Relative to: OMP_AN:27605 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CID:23615261) D-(+) Maltose monohydrate |
| ||
|
OMP_AN:35112 |
OMP:0007071 |
increased organic carbon source utilization |
Relative to: OMP_AN:27615 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CID:23615261) D-(+) Maltose monohydrate |
| ||
|
OMP_AN:35113 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27505 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CID:165528) Methotrexate hydrate |
| ||
|
OMP_AN:35114 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27510 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:27504) Mitomycin C |
| ||
|
OMP_AN:35115 |
OMP:0007074 |
increased growth factor requirement |
Relative to: OMP_AN:27600 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:31206) NH4Cl |
| ||
|
OMP_AN:35116 |
OMP:0007033 |
increased utilization of inorganic nitrogen source |
Relative to: OMP_AN:27610 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:31206) NH4Cl |
| ||
|
OMP_AN:35117 |
OMP:0007249 |
decreased resistance to a chemical |
Relative to: OMP_AN:27513 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:8055) Phenazine methosulfate (PMS) |
| ||
|
OMP_AN:35118 |
OMP:0007250 |
increased resistance to a chemical |
Relative to: OMP_AN:27573 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:8431) Procaine hydrochloride |
| ||
|
OMP_AN:35119 |
OMP:0007903 |
decreased resistance to bile acids |
Relative to: OMP_AN:27584 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CID:23687511) Taurocholic acid sodium salt hydrate |
| ||
|
OMP_AN:35120 |
OMP:0006058 |
increased resistance to aminoglycoside |
Relative to: OMP_AN:27529 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:28864) Tobramycin |
| ||
|
OMP_AN:35121 |
OMP:0007896 |
decreased resistance to a surfactant |
Relative to: OMP_AN:27583 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:9750) Triton X-100 |
| ||
|
OMP_AN:35122 |
OMP:0006044 |
decreased resistance to beta-lactam |
Relative to: OMP_AN:27532 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:161680) Aztreonam |
| ||
|
OMP_AN:35123 |
OMP:0006044 |
decreased resistance to beta-lactam |
Relative to: OMP_AN:27536 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:3509) Ceftazidime hydrate |
| ||
|
OMP_AN:35124 |
OMP:0006057 |
decreased resistance to aminoglycoside |
Relative to: OMP_AN:27526 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:5312) Gentamicin sulfate salt |
| ||
|
OMP_AN:35125 |
OMP:0007074 |
increased growth factor requirement |
Relative to: OMP_AN:27598 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:75836) Iron excess-FeSO4 heptahydride |
| ||
|
OMP_AN:35126 |
OMP:0007888 |
increased resistance to a metal |
Relative to: OMP_AN:27608 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:75836) Iron excess-FeSO4 heptahydride |
| ||
|
OMP_AN:35127 |
OMP:0007074 |
increased growth factor requirement |
Relative to: OMP_AN:27599 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:75836) Iron starvation-FeSO4·7H2O |
| ||
|
OMP_AN:35128 |
OMP:0007936 |
increased resistance to nutrient limitation |
Relative to: OMP_AN:27609 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:75836) Iron starvation-FeSO4·7H2O |
| ||
|
OMP_AN:35129 |
OMP:0007879 |
decreased resistance to an antimicrobial agent |
Relative to: OMP_AN:27504 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:31924) Novobiocin sodium salt |
| ||
|
OMP_AN:35130 |
OMP:0006036 |
decreased resistance to macrolide |
Relative to: OMP_AN:27521 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CID:6419898) Spiramycin |
| ||
|
OMP_AN:35131 |
OMP:0006063 |
increased resistance to tetracycline |
Relative to: OMP_AN:27524 Genotype differences: +lacZ4787(del)( +aspA765(del) -lacZ4787(del) Condition differences: no differences |
|
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
towards some (CHEBI:35006) Tetracycline hydrochloride |
| ||
Additional Information
Links
References
See Help:References for how to manage references in OMPwiki.
- ↑ Baba, T et al. (2006) Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2 2006.0008 PubMed OMPwiki page
- ↑ 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19 2.20 2.21 2.22 2.23 2.24 2.25 2.26 2.27 2.28 2.29 2.30 2.31 2.32 2.33 2.34 2.35 2.36 2.37 2.38 2.39 2.40 Nichols, RJ et al. (2011) Phenotypic landscape of a bacterial cell. Cell 144 143-56 PubMed OMPwiki page
o
- OMP:0006036 ! decreased resistance to macrolide
- OMP:0006040 ! decreased resistance to quinolone
- OMP:0006044 ! decreased resistance to beta-lactam
- OMP:0006057 ! decreased resistance to aminoglycoside
- OMP:0006058 ! increased resistance to aminoglycoside
- OMP:0006063 ! increased resistance to tetracycline
- OMP:0007033 ! increased utilization of inorganic nitrogen source
- OMP:0007071 ! increased organic carbon source utilization
- OMP:0007074 ! increased growth factor requirement
- OMP:0007249 ! decreased resistance to a chemical
- OMP:0007250 ! increased resistance to a chemical
- OMP:0007878 ! increased resistance to an antimicrobial agent
- OMP:0007879 ! decreased resistance to an antimicrobial agent
- OMP:0007888 ! increased resistance to a metal
- OMP:0007896 ! decreased resistance to a surfactant
- OMP:0007902 ! increased resistance to bile acids
- OMP:0007903 ! decreased resistance to bile acids
- OMP:0007936 ! increased resistance to nutrient limitation
